AbbVie (ABBV) is a publicly traded Healthcare sector company. As of August 10, 2026, ABBV trades at $245.60 with a market cap of $434.78B and a P/E ratio of 69.34. ABBV moved +0.43% today. Year to date, ABBV is +7.68%; over the trailing twelve months it is +23.73%. Its 52-week range spans $164.39 to $267.47. Analyst consensus is strong buy with an average price target of $276.05. Rallies surfaces ABBV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
AbbVie (ABBV) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. ABBV moved +0.43% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $245.60 |
| Market Cap | $434.78B |
| P/E Ratio | 69.34 |
| EPS | $3.54 |
| Dividend Yield | 1.73% |
| 52-Week High | $267.47 |
| 52-Week Low | $164.39 |
| Volume | 2.64M |
| Avg Volume | 0 |
| Revenue (TTM) | $64.39B |
| Net Income | $6.32B |
| Gross Margin | 71.48% |
23 analysts cover ABBV: 0 strong buy, 19 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $276.05.